Thus, four rare variants of DROSHA, predicted to damage protein function (P32L, P100L, K226E, R279L), are present at a much higher frequency in HHT patients compared with healthy controls, suggesting that they may contribute to the HHT onset [22]. This evidence concerns the gene DROSHA and hereditary hemorrhagic telangiectasia.